Spots Global Cancer Trial Database for bladder tumors
Every month we try and update this database with for bladder tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ | NCT00462488 | Urinary Bladder... Bladder Cancer Bladder Neoplas... Bladder Tumors | Vicinium | 18 Years - | Sesen Bio, Inc. | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | NCT02897765 | Urinary Bladder... Bladder Tumors Transitional Ce... Malignant Melan... Melanoma Skin Cancer Carcinoma, Non-... Lung Cancer | NEO-PV-01 Nivolumab Adjuvant | 18 Years - | BioNTech SE | |
| The Bladder Instillation Comparison Study | NCT02695771 | Urinary Bladder... | Mitomycin C Gemcitabine | 18 Years - | Spectrum Health Hospitals | |
| Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | NCT02496442 | Prostatic Hyper... Kidney Calculi Bladder Tumors | Aqueduct | 18 Years - | Flowmed | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| The Bladder Instillation Comparison Study | NCT02695771 | Urinary Bladder... | Mitomycin C Gemcitabine | 18 Years - | Spectrum Health Hospitals | |
| Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan | NCT02496442 | Prostatic Hyper... Kidney Calculi Bladder Tumors | Aqueduct | 18 Years - | Flowmed | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| Survivin Urine mRNA Assay Risk of Bladder Cancer Study | NCT00315653 | Bladder Cancer | 50 Years - | Fujirebio Diagnostics, Inc. | ||
| Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer | NCT05072600 | Bladder Cancer Bladder Neoplas... Bladder Tumors Urinary Bladder... Neoplasms, Blad... | Pembrolizumab | 18 Years - | Peking University First Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
